Suven Life gets patent for neuro-degenerative molecule
Tuesday, March 28, 2017, 2:52 PM
Drug firm Suven Life Sciences has received one product patent from New Zealand for its molecule to be used in the treatment of neuro degenerative diseases. With this new patent, Suven has a total of 26 patents from New Zealand. The new patent is valid through 2033, Suven Life Sciences said in a BSE filing.